Skip to content
healthcare.dev

Osenvelt

NDC 72606-038, denosumab-bmwo, injection, from CELLTRION USA, Inc..

Product NDC
72606-038
Status
Listed
Labeler
CELLTRION USA, Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761404
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72606-038 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DENOSUMAB120 mg/1.7mL

Pharmacologic classes

RANK Ligand Blocking Activity [MoA]; RANK Ligand Inhibitor [EPC]

Package NDCNDC-11Package
72606-038-01726060038011 VIAL, SINGLE-USE in 1 CARTON (72606-038-01) / 1.7 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c5a5d750-80be-49cd-b4a6-c8a815956059
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=72606-038

Use it

Look up 72606-038 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72606-038 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72606-038. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.